Clinical characteristics of polyglandular autoimmune syndromes in pediatric age: an observational study
Author:
Bouça Bruno1, Nogueira Andreia2, Caetano Joana3, Cardoso Rita3, Dinis Isabel3, Mirante Alice3
Affiliation:
1. Endocrinology, Diabetes and Metabolism Department , Centro Hospitalar Universitário Lisboa Central , Lisbon , Portugal 2. Pediatrics Department , Centro Hospitalar Universitário de Coimbra , Coimbra , Portugal 3. Pediatric Endocrinology Diabetes and Growth Department , Centro Hospitalar Universitário de Coimbra , Coimbra , Portugal
Abstract
Abstract
Objectives
Polyglandular autoimmune syndromes (PAS) are characterized by the association of two or more autoimmune diseases (AID) and are classified into four types. PAS type 1 is more frequently manifested in childhood, but the prevalence of other PAS in children, less described in the literature, seems to be underestimated.
Methods
This study aimed to evaluate the prevalence of PAS in a selected pediatric population of 879 children with Diabetes mellitus type 1 (DM1), autoimmune thyroid disease (AITD), and Addison’s disease (AD) followed in our hospital for 10 years and describe and classify the manifestations of different PAS.
Results
We diagnosed 35 children with PAS, most fulfilled criteria for PAS type 3 (65.7%), and AITD was the AID more frequently detected (74.3%). PAS type 1 was not diagnosed in our sample. Patients with PAS manifested DM1 and AITD at a younger age than children with monoglandular pathology (7.7 vs. 9.3 years, p=0.04 and 7.7 vs. 13.1 years, p<0.01).
Conclusions
This is the first study that analyzes the prevalence of different types of PAS in a pediatric population followed by endocrine pathologies, namely DM1, AD, and AITD. As PAS manifestations are often preceded by a long latency period characterized by the presence of autoantibodies, we reinforce the need to value these markers for timely diagnosis and to screen PAS in patients with AD throughout their lives.
Publisher
Walter de Gruyter GmbH
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health
Reference26 articles.
1. Husebye, ES, Anderson, MS, Kämpe, O. Autoimmune polyendocrine syndromes. N Engl J Med 2018;378:1132–41. https://doi.org/10.1056/nejmra1713301. 2. Pham-Dobor, G, Hanák, L, Hegyi, P, Márta, K, Párniczky, A, Gergics, M. Prevalence of other autoimmune diseases in polyglandular autoimmune syndromes type II and III. J Endocrinol Invest 2020;43:1–9. https://doi.org/10.1007/s40618-020-01229-1. 3. Neufeld, M, Blizzard, RM. Polyglandular autoimmune disease. In: Pinchera, A, Doniach, D, Fenzi, DF, Baschieri, L, editors. Autoimmune aspects of endocrine disorders. London, UK: Academic Press; 1980:357–65 pp. 4. Betterle, C, Zanchetta, R. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed 2003;74:9–33. 5. Schneller, C, Finkel, L, Wise, M, Hageman, JR, Littlejohn, E. Autoimmune polyendocrine syndrome: a case-based review. Pediatr Ann 2013;42:203–8. https://doi.org/10.3928/00904481-20130426-12.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|